Company intelligence / Profile preview

Loop Diagnostics

Barcelona, Catalonia, Spain

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

Loop Diagnostics has developed SeptiLoop—a blood test for early detection of sepsis immunosuppression caused by bacteremia. The technology analyzes changes in gene expression and immune profiles to enable earlier diagnosis than traditional clinical signs. Products are currently undergoing certification for CE marking as in vitro diagnostic devices; not yet commercially available but used for research/performance evaluation purposes

Therapeutic areas: Infectious Diseases
Modalities: DeviceIn vitro diagnostic device
Industry: Molecular Diagnostics

Partnerships

None publicly disclosed.

Beyond the preview

Go deeper on Loop Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Loop Diagnostics.

Explore the full profile